862 J . Org. Chem., Vol. 63, No. 3, 1998
Notes
200.13, 400.13, or 500.14 MHz operational frequencies for 1H
observations and 50.32 and 100.62 MHz for 13C observations.
Chemical shifts are reported in parts per million relative to
CDCl3 (7.24 ppm for 1H NMR and 77.0 ppm for 13C NMR) as
the internal standard. 1H NMR coupling constant determina-
tions (J -values reported in Hz) and nuclei assignments were
aided by the use of homonuclear decoupling experiments. 13C
NMR resonance assignments were aided by use of the DEPT
technique to determine numbers of attached hydrogens. Infra-
red (IR) spectra were obtained on samples which were prepared
as neat liquids unless otherwise noted, and band assignments
-0.01 (B) and 0.09 (A) (s, 9H, TMS), 2.81(B) and 2.86 (A) (s,
2H, CH2TMS), 3.01 (A and B) (m, 2H, ArCH2), 3.55 (A and B)
(m, 2H, CH2N), 5.10 (A) and 5.15 (B) (OCH2Ar), 7.18 (A and B)
(m, 8H, Ar), 7.68 (A and B) (m, 1H, Ar), 8.01 (s, 1H, NH); 13C
NMR -1.06 (B) and -0.94 (A) (TMS) 23.9 (A) and 24.6 (A) (CH2-
TMS), 39.1 (B) and 39.7 (A) (ArCH2), 50.6 (A) and 51.1 (B)
(CH2N), 67.6 (B) and 67.7 (A) (OCH2Ar), 113.4, 128.0, 111.7,
119.2, 119.7, 119.8, 122.3, 122.5, 122.7, 128.2, 128.3, 128.4, 128.6,
129.0, 129.3, 136.8, 137.4 (Ar) 156.7 (CdO); IR 3416, 3319, 3090,
2908, 1699, 1448; EIMS 380 (M, 4), 289 (24), 234 (20), 206 (28),
130 (30); HRMS 380.1917, C22H28N2O2Si requires 380.1920.
A solution of 11 (2.50 g, 6.60 mmol) and sodium hydride (0.29
g, 6.60 mmol) in 30 mL of THF was stirred at reflux for 1.5 h
before adding benzene sulfonyl chloride (1.17 g, 6.60 mmol),
stirring at reflux for 1.5 h, cooling to 25 °C, and concentrating
in vacuo. The residue was triturated with CH2Cl2, and the
triturate was dried and concentrated in vacuo to give a residue
which was subjected to column chromatography (silica gel, 1:3
ethyl acetate-hexane) to yield 1.72 g (50%) of 12 (rotamer A:B
are in units of cm-1
. Mass spectrometric data determined by
use of either the electron impact (EIMS), chemical ionization
(CIMS), or fast atom bombardment (FAB) method are reported
as m/z (relative intensity), and high-resolution mass spectral
data (HRMS) are recorded as m/z. All new compounds were
obtained as oils in >90% purity (by 1H and 13C NMR analysis)
unless otherwise noted. Column chromatographic separations
were performed by using EM Type 60 silica gel (230-400 mesh),
Florisil (100-200 mesh), or Type F-20 Alumina (neutral, 80-
120 mesh). Preparative TLC was performed on 20 × 20 cm
plates coated with EM Type-60 GF-254 silica gel.
1
) 1.2:1) H NMR -0.01 (B) and 0.09 (A) (s, 3H, TMS), 2.68 (B)
and 2.78 (A) (s, 2H, CH2TMS), 2.93 (A and B) (m, 2H, ArCH2),
3.51 (A and B) (m, 2H, CH2N), 5.04 (A) and 5.16 (B) (s, 2H, OCH2-
Ar), 7.14 (A and B) (m, 1H, Ar), 7.40 (A and B) (m, 11H, Ar),
7.85 (A and B) (m, 2H, Ar), 8.02 (A and B) (m, 1H, Ar); 13C NMR
-1.16 (B) and -0.99 (A) (TMS), 23.7 (B) and 24.4 (A) (ArCH2),
39.4 (B) and 39.7 (A) (CH2TMS), 49.5 (A) and 50.1 (B) (CH2N),
67.7 (A and B) (OCH2Ar), 119.9 and 120.3, 114.2, 123.8, 125.3,
127.2, 128.6, 128.7, 129.0, 129.3, 129.4, 129.7, 129.9, 131.2 and
131.4, 135.8 and 137.3 and 138.7 (Ar), 156.3 (A) and 156.5 (B)
(CdO); IR 3090, 2953, 1693, 1464; EIMS 506 (M, 9), 429 (77),
270 (45), 233 (33), 206 (100); HRMS 506.1704, C27H30N2O4SiS
requires 506.1696.
A solution of 12 (0.23 g, 0.44 mmol) and CAN (0.49 g, 0.88
mmol) in 25 mL of anhydrous acetonitrile was stirred at 24 °C
for 6 h, diluted with CH2Cl2, and filtered. The filtrate was
washed with brine, dried, and concentrated in vacuo, giving a
residue which was subjected to column chromatography (silica
gel, 1:2 ethyl acetate-hexane) to give 168 mg (86%) of carbazole
13: (rotamer A:B ) 1:1) 1H NMR 2.72 (m, 2H, ArCH2), 3.79 (m,
2H, CH2N), 5.02 (s, 2H, ArCH2Ar), 5.22 (s, 2H, ArCH2N), 7.32
(m, 11H, Ar), 7.77 (m, 1H, Ar), 7.89 (m, 1H, Ar), 8.17 (m, 1H,
Ar). 13C NMR 21.6 and 22.1 (ArCH2), 41.0 (ArCH2N), 43.9
(CH2N) 68.0 (OCH2Ar),117.0 117.6 (ArCH2CH2N ArC7 quater-
nary), 114.1, 118.3, 123.5, 124.6, 126.2, 127.8, 128.0, 128.4, 129.2,
129.3, 133.7, 130.7, 131.2, 135.9, 136.4, 138.1 (Ar), 155.3 (CdO);
IR 3067, 2920, 1703, 1427; EIMS 446 (M, 1), 355 (100), 214 (34);
HRMS 446.1294, C25H22N2O4S requires 446.1256.
Rep r esen ta tive P r oced u r es. P r ep a r a tion a n d CAN-
P r om oted Cycliza tion of Ben zyl N-[2-(3,4-Dim eth oxyp h en -
yl)eth -1-yl]-N-[(tr im eth ylsilyl)m eth yl]ca r ba m a te (2b).
A
mixture of benzyl N-[2-(3,4-dimethoxyphenyl)eth-1-yl]carbamate
(1b)12 (5.00 g, 15.8 mmol) and sodium hydride (0.69 g, 15.8 mmol)
in 25 mL of THF was stirred at 0 °C for 1 h. (Trimethylsilyl-
)methyl iodide (4.00 g, 19.0 mmol) was added, and the mixture
was stirred at reflux for 19 h and concentrated in vacuo, giving
a residue which was triturated with CH2Cl2. The triturate was
dried and concentrated in vacuo to give a residue which was
subjected to column chromatography (silica gel, 1:3 ethyl acetate:
hexane) to yield 1.48 g (23%) of 2b: (rotamer A:B ) 1.3:1) 1H
NMR 0.01 (A) and 0.08 (B) (s, 9H, TMS), 2.80 (A and B) (m, 4H,
CH2TMS and ArCH2), 3.43 (A and B) (m, 2H, CH2N), 3.78 (A)
and 3.85 (B) (s, 6H, CH3O), 5.09 (A) and 5.11 (B) (s, 2H, CH2-
Ph), 6.70 (A and B) and 7.35 (A and B) (m, 8H, Ar and Ph); 13
C
NMR -1.06 (B) and -1.02 (A) (TMS), 34.5 (B) and 34.6 (A)
(ArCH2), 39.5 (B) and 39.6 (A) (TMS), 51.6 (A) and 52.1 (B)
(CH2N), 56.3 and 56.4 (A and B) (CH3O), 67.5 (A and B) (CH2-
Ar), 111.9, 112.6, 121.2, 128.4, 128.5, 128.6, 128.7, 128.8, 132.1,
137.5 and 137.6, 148.1, 149.5, 156.4 (Ar and Ph), 156.4 (CdO);
IR 3032, 2953, 1703, 1516; EIMS 401 (M, 5), 386 (34), 310 (72),
294 (36), 206 (71), 151 (42), 91 (100); HRMS 401.2009, C22H31
NO4Si requires 401.2022.
-
A solution of 2b (0.100 g, 0.258 mmol) and CAN (0.283 g, 0.515
mmol) in 10 mL of anhydrous acetonitrile was stirred at 25 °C
for 18 h, diluted with CH2Cl2, and filtered. The filtrate was
washed with brine, dried, and concentrated in vacuo, giving a
residue which was subjected to column chromatography (silica
gel, 1:2 ethyl acetate-hexane) to give 47 mg (60%) of tetrahy-
droisoquinoline 3b. 1H NMR 2.78 (t, J ) 5.5, 2H, (ArCH2), 3.72
(t, J ) 5.5, 2H, (CH2N), 3.86 (s, 6H, (CH3O), 4.58 (s, 2H,
(ArCH2N), 5.18 (s, 2H, OCH2Ar), 6.63(m, 2H, Ar), 7.36 (m, 5H,
Ar); 13C NMR 28.8 (ArCH2), 42.0 (CH2N), 45.9 (ArCH2N), 56.3
(CH3O), 67.5 (OCH2Ar), 109.7, 112.1, 125.2, 125.4, 126.7, 128.9,
128.4, 137.3, 148.1, 148.2 (Ar), 155.8 (CdO); IR 3080, 2935, 1632,
1518; EIMS 327 (M, 2), 236 (100), 91 (38); HRMS 327.1466,
C19H21NO4 requires 327.1471.
P r ep a r a tion a n d CAN-P r om oted Cycliza tion of [1-[(Tr i-
m e t h y ls ily l)m e t h y l]-2-o x o p y r r o lid in -5-y l][9-P h e n a n -
th r en yl]m eth yl Aceta te (15). A solution of phenanthrenyl
alcohol 148 (112 mg, 0.20 mmol), DMAP (11 mg, 0.09 mmol),
and acetic anhydride (0.20 mL, 0.22 g, 2.1 mmol) in pryridine
(3 mL) was stirred at 25 °C for 17 h, diluted with H2O, and
extracted with CH2Cl2. The extracts were washed with 5% HCl,
satd NaHCO3, and H2O, dried, and concentrated in vacuo to
provide a residue which was subjected to column chromatogra-
phy (Florisil, Et2O), yielding 83 mg (75%) of the acetate 15: 1H
NMR 0.01 (s, 9 H, Si(CH3)3), 1.75 (m, 1 H, CH2), 1.92 (m, 1 H,
CH2), 2.18 (m, 1 H, CH2), 2.16 (s, 3 H, CH3), 2.34 (m, 1 H, CH2),
2.41 and 3.35 (ABq, J ) 15.2, 2 H, SiCH2N), 4.23 (ddd, J ) 8.6,
6.6, and 2.4, 1 H, CH), 6.49 (d, J ) 6.6, 1 H, CHOAc), 7.65 (m,
4 H, Ar), 7.79 (s, 1 H, Ar H-10), 7.88 (dd, J ) 7.9 and 1.1, 1 H,
Ar), 8.20 (d, J ) 9.5, 1 H, Ar), 8.65 (d, J ) 8.2, 1 H, Ar H-4 or
H-5), 8.75 (dd, J ) 7.7 and 2.0, 1 H, Ar H-4 or H-5); 13C NMR
-1.3 (TMS), 21.3 (CH3CO), 22.9 (CH2), 29.4 (CH2), 34.6 (SiCH2N),
62.8(CH), 122.5, 123.6, 123.7, 126.6, 126.8, 126.99, 127.05, 127.4,
128.8, 129.4, 130.3, 130.7, 130.8, 132.0 (Ar), 169.6 (OCO), 174.5
(NCO); IR 3050, 2954, 1747, 1682; CIMS 421 (M+1, 1), 170 (100),
74 (30); HRMS 420.19875, C25H30O3NSi requires 420.19949.
A solution of 15 (38 mg, 0.091 mmol) and CAN (218 mg, 0.4
mmol) in 1.5 mL of anhydrous acetonitrile was stirred at 25 °C
for 18 h, diluted with satd NaHCO3, and extracted with CH2-
Cl2. The extracts were washed with brine, dried, and concen-
trated in vacuo to give a residue which was subjected to HPLC
(reverse phase C-18, Et2O to 4:1 Et2O-acetone) to provide 17
mg (54%) of indolizidine 16: 1H NMR 2.09 (m, 1 H, CH2), 2.05
(s, 3 H, CH3CO), 2.37 (m, 1 H, CH2), 2.52 (m, 2 H, CH2), 4.12
P r ep a r a tion a n d CAN-P r om oted Cycliza tion of Ben zyl
N-[(N-Ben zen esu lfon yl)-â-t r yt op h yl]-N-[(t r im et h ylsilyl)-
m eth yl]ca r ba m a te (12). A solution of tryptamine (1.50 g, 9.35
mmol), triethylamine (0.95 g, 9.35 mmol), and (trimethylsilyl-
)methyl iodide (2.67 g, 9.35 mmol) in 50 mL of CH2Cl2 was
stirred at reflux for 6 h, cooled, washed with H2O, dried, and
concentrated in vacuo. To a solution of the residue and triethy-
lamine (0.95 g, 9.35 mmol) in 50 mL of CH2Cl2 was added benzyl
chloroformate (2.13 g, 9.35 mmol) in 20 mL of CH2Cl2, and the
mixture was stirred for 2 h at 25 °C, washed with H2O, dried,
and concentrated in vacuo to give a residue which was subjected
to column chromatography (silica gel, 1:3 ethyl acetate-hexane)
1
to yield 2.52 g (71%) of 11: rotamers A and B, 1.8:1) H NMR
(12) Umino, N.; Iwakuma, T.; Itoh, N. Tetrahedron Lett. 1976, 10,
763.